These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 20658279)
1. Stabilization of human urine doping control samples: IV. Human chorionic gonadotropin. Tsivou M; Dimopoulou HA; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG Anal Bioanal Chem; 2010 Oct; 398(3):1313-8. PubMed ID: 20658279 [TBL] [Abstract][Full Text] [Related]
2. Stabilization of human urine doping control samples: III. Recombinant human erythropoietin. Tsivou M; Dimopoulou HA; Leontiou IP; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG Clin Chim Acta; 2010 Mar; 411(5-6):448-52. PubMed ID: 19958754 [TBL] [Abstract][Full Text] [Related]
3. Doping control container for urine stabilization: a pilot study. Tsivou M; Giannadaki E; Hooghe F; Roels K; Van Gansbeke W; Garribba F; Lyris E; Deventer K; Mazzarino M; Donati F; Georgakopoulos DG; Van Eenoo P; Georgakopoulos CG; de la Torre X; Botrè F Drug Test Anal; 2017 May; 9(5):699-712. PubMed ID: 27497113 [TBL] [Abstract][Full Text] [Related]
4. Stabilization of human urine doping control samples: a current opinion. Tsivou M; Georgakopoulos DG; Dimopoulou HA; Koupparis MA; Atta-Politou J; Georgakopoulos CG Anal Bioanal Chem; 2011 Aug; 401(2):553-61. PubMed ID: 21499681 [TBL] [Abstract][Full Text] [Related]
5. Stabilization of human urine doping control samples: II. microbial degradation of steroids. Tsivou M; Livadara D; Georgakopoulos DG; Koupparis MA; Atta-Politou J; Georgakopoulos CG Anal Biochem; 2009 May; 388(1):146-54. PubMed ID: 19232313 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes. Robinson N; Sottas PE; Saugy M Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467 [TBL] [Abstract][Full Text] [Related]
7. Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control. Kuuranne T; Ahola L; Pussinen C; Leinonen A Drug Test Anal; 2013 Aug; 5(8):614-8. PubMed ID: 23303576 [TBL] [Abstract][Full Text] [Related]
8. Analytic evaluation of the beta-human chorionic gonadotropin assay on the Abbott IMx and Elecsys2010 for its use in doping control. Shahzad K; Kim DH; Kang MJ Clin Biochem; 2007 Nov; 40(16-17):1259-65. PubMed ID: 17884034 [TBL] [Abstract][Full Text] [Related]
9. Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use. Butch AW; Ahrens BD; Avliyakulov NK Drug Test Anal; 2018 Jun; 10(6):956-960. PubMed ID: 29098788 [TBL] [Abstract][Full Text] [Related]
10. Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis. Lund H; Snilsberg AH; Halvorsen TG; Hemmersbach P; Reubsaet L Bioanalysis; 2013 Mar; 5(5):623-30. PubMed ID: 23425277 [TBL] [Abstract][Full Text] [Related]
11. Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations. Strahm E; Marques-Vidal P; Pralong F; Dvorak J; Saugy M; Baume N Forensic Sci Int; 2011 Dec; 213(1-3):62-72. PubMed ID: 21798680 [TBL] [Abstract][Full Text] [Related]
12. Doping control of testosterone and human chorionic gonadotrophin: a case study. de Boer D; de Jong EG; van Rossum JM; Maes RA Int J Sports Med; 1991 Feb; 12(1):46-51. PubMed ID: 2030059 [TBL] [Abstract][Full Text] [Related]
13. Loss of human chorionic gonadotropin in urine during storage at -20°C. Lempiäinen A; Hotakainen K; Alfthan H; Stenman UH Clin Chim Acta; 2012 Jan; 413(1-2):232-6. PubMed ID: 21988940 [TBL] [Abstract][Full Text] [Related]
14. Separation of nicked human chorionic gonadotropin (hCG), intact hCG, and hCG beta fragment from standard reference preparations and raw urine samples. Birken S; Chen Y; Gawinowicz MA; Lustbader JW; Pollak S; Agosto G; Buck R; O'Connor J Endocrinology; 1993 Sep; 133(3):1390-7. PubMed ID: 7689955 [TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men. Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708 [TBL] [Abstract][Full Text] [Related]
16. The heterogeneity of human chorionic gonadotropin (hCG). III. The occurrence and biological and immunological activities of nicked hCG. Cole LA; Kardana A; Andrade-Gordon P; Gawinowicz MA; Morris JC; Bergert ER; O'Connor J; Birken S Endocrinology; 1991 Sep; 129(3):1559-67. PubMed ID: 1714836 [TBL] [Abstract][Full Text] [Related]
17. A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements. Albersen A; Kemper-Proper E; Thelen MH; Kianmanesh Rad NA; Hoedemaeker RF; Boesten LS Clin Chem Lab Med; 2011 Jun; 49(6):1029-32. PubMed ID: 21410410 [TBL] [Abstract][Full Text] [Related]
18. "Application of the ultra micro analytical system (SUMA) technology for the detection of urinary hCG in antidoping control". Martinez Brito D; Bueno Fis E; Fiallo Fernandez T; Torres Castellanos M; Correa Vidal MT; Montes De Oca Porto R J Immunoassay Immunochem; 2018; 39(6):672-686. PubMed ID: 30346873 [TBL] [Abstract][Full Text] [Related]
19. Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males. Lund H; Snilsberg AH; Paus E; Halvorsen TG; Hemmersbach P; Reubsaet L Anal Bioanal Chem; 2013 Feb; 405(5):1569-76. PubMed ID: 23203507 [TBL] [Abstract][Full Text] [Related]
20. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies. O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]